BARBARA BRUNE: Open Payments
NPI 1912692831 · ALEXANDRIA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$593 in 23 payments from 15 companies in 2025. Trend: 2023 $508 · 2024 $806 · 2025 $593
Food & beverage: $593
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $112 |
| Daiichi Sankyo Inc. | 3 | $69 |
| Merck Sharp & Dohme LLC | 3 | $68 |
| Novartis Pharmaceuticals Corporation | 2 | $53 |
| AstraZeneca Pharmaceuticals LP | 2 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $33 |
| Stemline Therapeutics Inc. | 1 | $28 |
| Genentech USA, Inc. | 1 | $28 |
| PharmaEssentia USA Corporation | 1 | $27 |
| Lilly USA, LLC | 1 | $26 |
Products named: KEYTRUDA, Enhertu, RYBREVANT, TECVAYLI, TALVEY, NINLARO, PLUVICTO, Orserdu.
Industry payments across VA — which companies pay providers there.
